Rs 320 10 % Off
Package size
Estimate Delivery by:
Delivering to
Easy 7 days return available
Alnaparin 40mg Injection is an anticoagulant medicine used to prevent and treat harmful blood clots. It helps stop existing clots from growing larger and reduces the formation of new clots. It is used in conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), and acute coronary syndrome. Alnaparin 40mg Injection is administered under the skin by a doctor or nurse. It should not be injected into a muscle. The dose and duration of the treatment are based on your medical condition, your response to the medicine, and what you are being treated for. While on treatment with this medicine, avoid activities that increase your risk of bleeding or injury. Common side effects of this medicine include injection site pain, bleeding, headache, increased blood platelets, breathing problems, edema, anemia, fever, diarrhea, and increased liver enzymes. A severe headache could be a sign of bleeding in the brain. A severe stomach ache could be a sign of bleeding in the stomach. Bleeding can be dangerous and may not be obvious. Look out for symptoms and tell your doctor if you are worried. Before receiving this medicine, let your doctor know if you have high blood pressure, diabetes, or have had a recent stroke. You should not take it if you have any current bleeding. Some medicines should not be used with Alnaparin 40mg Injection. Let your doctor know about all the medicines you are taking to make sure it is safe. If you have low body weight, you may be at increased risk of bleeding, and drinking alcohol can increase the risk of stomach bleeding.
Uses: Treatment of Deep vein thrombosis | Pulmonary embolism | Acute coronary syndrome Benefits: Treatment of Deep vein thrombosis Alnaparin 40mg Injection is used for the treatment of acute deep vein thrombosis. It helps prevent further clot formation, limits clot extension, and reduces the risk of recurrence through effective anticoagulation. Pulmonary embolism In pulmonary embolism (PE), Alnaparin 40mg Injection helps stabilise existing clots and prevents new clots from forming in the pulmonary circulation. It is indicated for the treatment of PE not requiring thrombolytic therapy or surgery and supports both initial and extended treatment to reduce recurrence risk. Acute coronary syndrome Alnaparin 40mg Injection is used in acute coronary syndromes, including unstable angina, non-ST-elevation myocardial infarction (NSTEMI), and ST-elevation myocardial infarction (STEMI). When used with antiplatelet therapy, it helps prevent further thrombus formation in coronary arteries and reduces the risk of myocardial infarction and death during plaque rupture.
Alnaparin 40mg Injection works by slowing down the blood-clotting process in the body. It helps stop existing clots from growing bigger and prevents new clots from forming. This reduces the risk of clots blocking blood flow in the veins or arteries, helping protect the heart, lungs, and circulation during treatment.
Your doctor or nurse will use this device to give medicine. You or your care giver may be taught on how to use this device at home.
Safety Advice: Alcohol: It is not known whether it is safe to consume alcohol with Alnaparin 40mg Injection. Please consult your doctor. Pregnancy: The safety of Alnaparin 40mg Injection during pregnancy has not been established. There are no adequate and well-controlled studies in pregnant women, and animal data on reproductive toxicity are insufficient. Your doctor will weigh the benefits and any potential risks before prescribing. Breast feeding: Alnaparin 40mg Injection may be safe to use during breastfeeding. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Alnaparin 40mg Injection is released in small amounts in the breast milk and amounts reaching the baby are also small, which would not be expected to cause any harmful effects to the baby. Driving: Alnaparin 40mg Injection does not usually affect your ability to drive. Kidney: Alnaparin 40mg Injection should be used with caution in patients with severe kidney disease. Dose adjustment may be needed. Liver: There is limited data available on the use of Alnaparin 40mg Injection in patients with liver disease.
However, cautious use is advised in patients with underlying liver disease.
Side Effects: Anemia (low number of red blood cells) | Edema (swelling) | Diarrhea | Low blood platelets | Bleeding | Headache | Increased liver enzymes | Fever | Injection site pain | Breathing problems
Storage: Cold stored between 2-8°C
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s